Wile G.E. Leyendecker J.R.

Magnetic resonance imaging of the liver: sequence optimization and artifacts.

Magn Reson Imaging Clin N Am. 2010; 18 (xi): 525-547

Focal manifestations of diffuse liver disease at MR imaging.

Radiology. 1992; 185: 1-11Venkataraman S. Braga L. Semelka R.C.

Imaging the fatty liver.

Magn Reson Imaging Clin N Am. 2002; 10: 93-103Labranche R. Gilbert G. Cerny M. et al.

Liver iron quantification with MR imaging: a primer for radiologists.

Radiographics. 2018; 38: 392-412

Diffusion-weighted MRI in the body: applications and challenges in oncology.

AJR Am J Roentgenol. 2007; 188: 1622-1635Bammer R. Holdsworth S.J. Veldhuis W.B. et al.

New methods in diffusion-weighted and diffusion tensor imaging.

Magn Reson Imaging Clin N Am. 2009; 17: 175-204Tang A. Tan J. Sun M. et al.

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Radiology. 2013; 267: 422-431Henninger B. Alustiza J. Garbowski M. et al.

Practical guide to quantification of hepatic iron with MRI.

Eur Radiol. 2020; 30: 383-393Hoodeshenas S. Yin M. Venkatesh S.K.

Magnetic resonance elastography of liver: current update.

Top Magn Reson Imaging. 2018; 27: 319-333Venkatesh S.K. Yin M. Ehman R.L.

Magnetic resonance elastography of liver: technique, analysis, and clinical applications.

J Magn Reson Imaging. 2013; 37: 544-555Chen J. Yin M. Glaser K.J. et al.

MR elastography of liver disease: state of the art.

Appl Radiol. 2013; 42: 5-12Griffin N. Charles-Edwards G. Grant L.A.

Magnetic resonance cholangiopancreatography: the ABC of MRCP.

Insights Imaging. 2012; 3: 11-21Paik J.M. Henry L. De Avila L. et al.

Mortality related to nonalcoholic fatty liver disease is increasing in the United States.

Hepatol Commun. 2019; 3: 1459-1471Younossi Z.M. Stepanova M. Younossi Y. et al.

Epidemiology of chronic liver diseases in the USA in the past three decades.

Gut. 2020; 69: 564-568Harrison S.A. Bashir M.R. Guy C.D. et al.

Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet. 2019; 394: 2012-2024Matsui O. Kadoya M. Takahashi S. et al.

Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage.

AJR Am J Roentgenol. 1995; 164: 1137-1140Fleming R.E. Britton R.S. Waheed A. et al.

Pathophysiology of hereditary hemochromatosis.

Semin Liver Dis. 2005; 25: 411-419Bacon B.R. Adams P.C. Kowdley K.V. et al.Diseases AAftSoL

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Hepatology. 2011; 54: 328-343Queiroz-Andrade M. Blasbalg R. Ortega C.D. et al.

MR imaging findings of iron overload.

Radiographics. 2009; 29: 1575-1589Guyader D. Gandon Y. Sapey T. et al.

Magnetic resonance iron-free nodules in genetic hemochromatosis.

Am J Gastroenterol. 1999; 94: 1083-1086

Liver inflammation and fibrosis.

J Clin Invest. 2017; 127: 55-64Yin M. Glaser K.J. Manduca A. et al.

Distinguishing between hepatic inflammation and fibrosis with MR elastography.

Radiology. 2017; 284: 694-705

Hepatitis B Facts and Figures. The Hepatitis B Foundation.

(Available at:) (Accessed January 31, 2020)Murphy S.L. Xu J. Kochanek K.D. et al.

Mortality in the United States, 2017.

NCHS Data Brief. 2018; : 1-8Hussain S.M. Reinhold C. Mitchell D.G.

Cirrhosis and lesion characterization at MR imaging.

Radiographics. 2009; 29: 1637-1652

Ledipasvir/Sofosbuvir (harvoni): improving options for hepatitis C virus infection.

P T. 2015; 40: 256-276

Health and economic burden of nonalcoholic fatty liver disease in the United States and its impact on veterans.

Fed Pract. 2019; 36: 14-19Parikh N.D. Marrero W.J. Wang J. et al.

Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States.

Hepatology. 2019; 70: 487-495Chundru S. Kalb B. Arif-Tiwari H. et al.

MRI of diffuse liver disease: characteristics of acute and chronic diseases.

Diagn Interv Radiol. 2014; 20: 200-208Alter M.J. Kruszon-Moran D. Nainan O.V. et al.

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

N Engl J Med. 1999; 341: 556-562Scaglione S. Kliethermes S. Cao G. et al.

The epidemiology of cirrhosis in the United States: a population-based study.

J Clin Gastroenterol. 2015; 49: 690-696Heidelbaugh J.J. Bruderly M.

Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.

Am Fam Physician. 2006; 74: 756-762Horowitz J.M. Venkatesh S.K. Ehman R.L. et al.

Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Abdom Radiol (NY). 2017; 42: 2037-2053Papadatos D. Fowler K.J. Kielar A.Z. et al.

Cirrhosis and LI-RADS.

Abdom Radiol (NY). 2018; 43: 26-40Khoshpouri P. Habibabadi R.R. Hazhirkarzar B. et al.

Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up.

Radiographics. 2019; 39: 1938-1964

Immunoglobulin G4-related sclerosing cholangitis.

J Dig Dis. 2019; 20: 357-362Palmela C. Peerani F. Castaneda D. et al.

Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features.

Gut Liver. 2018; 12: 17-29Wells M.L. Fenstad E.R. Poterucha J.T. et al.

Imaging findings of congestive hepatopathy.

Radiographics. 2016; 36: 1024-1037American College of Radiology

The LI-RADS v2018 Manual.

(Available at:) (Accessed June 6, 2020)